Drugs / NKF-INS(A)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06492226 | Jul → Oct 2024 | — | Xentria, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NKF-INS(A) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06492226 ↗ |